Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Rank in Stocks #118
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Share Price
$97.46
Last synced: 2026-10-02
Market Cap
$168.63B
Change (1 day)
0.77%
Change (1 year)
-27.59%
Country
US
Trade Abbott Laboratories (ABT)

Category

Number of shares outstanding for Abbott Laboratories (ABT)
Number of shares outstanding as of June 2026: 1.74B
According to Abbott Laboratories latest financial reports and stock price the company's current number of shares outstanding is 1.74B. At the end of December 2024 the company had 1.73B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Abbott Laboratories (ABT) from 2000 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 1.74B -0.23%
2025 1.75B 0.88%
2024 1.73B -0.14%
2023 1.73B -1.08%
2022 1.75B -1.24%
2021 1.78B 0.11%
2020 1.77B 0.28%
2019 1.77B 0.71%
2018 1.76B 0.69%
2017 1.74B 18.38%
2016 1.47B 0.01%
2015 1.47B -2.35%
2014 1.51B -2.59%
2013 1.55B -1.81%
2012 1.58B 0.40%
2011 1.57B 1.51%
2010 1.55B 0.03%
2009 1.55B 0.19%
2008 1.54B 0.03%
2007 1.54B 0.87%
2006 1.53B -1.46%
2005 1.55B -0.52%
2004 1.56B -0.14%
2003 1.56B 0.12%
2002 1.56B 0.68%
2001 1.55B 0.15%
2000 1.55B 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
1.28B -26.45%
IE
383.50M -78.00%
US
1.48B -15.23%
US
- -
DE
576.40M -66.93%
US